Showing results (201-210 of 427) with videos related to

Sort By:
Pageof 43
Haematologica|February 19, 2011
Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physiciansEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Cancer Medicine|April 23, 2020
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, et al.
Leukemia & Lymphoma|April 7, 2009
Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experienceClaudio Cartoni, Pasquale Niscola, Massimo Breccia, et al.
Annals of Hematology|September 20, 2025
Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registriesMassimo Breccia, Simone Celant, Francesca Palandri, et al.
American Journal of Hematology|November 26, 2002
Conservative treatment for patients over 80 years with acute myelogenous leukemiaRoberto Latagliata, Giuliana Alimena, Ida Carmosino, et al.
Leukemia & Lymphoma|April 28, 2025
CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITD<sup>mut</sup>-AML): a flow-cytometric marker for an accurate diagnostic workupAlessandro Laganà, Deborah Kasmi, Daniela Diverio, et al.
American Journal of Hematology|October 29, 2014
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinibRoberto Latagliata, Paola Volpicelli, Massimo Breccia, et al.
Cancers|August 29, 2024
Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 YearsSaveria Capria, Silvia Maria Trisolini, Lorenzo Torrieri, et al.
Leukemia & Lymphoma|November 17, 2025
Hemoglobin changes during long-lasting frontline treatment with Tyrosine-Kinase inhibitors in patients with chronic myeloid leukemiaRoberto Latagliata, Ida Carmosino, Ambra Di Veroli, et al.
Blood Reviews|March 6, 2026
Underreported and underreviewed: Addressing the gaps in TKI tolerability literature for chronic myeloid leukemiaDennis Dong Hwan Kim, Daniela Zackova, Massimo Breccia, et al.
Pageof 43